Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993667 · ClinicalTrials.gov registry record · Phase 4
Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
A Phase 4 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT01993667 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 130 participants.
The verdict
NCT01993667, a Phase 4 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
Interventions
- DRUG Low Dose Acetazolamide
- DRUG Normal Dose Acetazolamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01993667
The ClinicalTrials.gov registry entry for NCT01993667 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Dose Acetazolamide is the first listed.
NCT01993667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01993667 about?
NCT01993667 is a clinical study titled "Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing". This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
What is the current status of trial NCT01993667?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2012-03. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01993667?
The interventions under investigation include: Low Dose Acetazolamide (DRUG), Normal Dose Acetazolamide (DRUG).
Who is sponsoring clinical trial NCT01993667?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.